Vanda Pharmaceuticals Inc.
VNDA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$22,586 | -$27,207 | -$29,494 | -$4,912 |
| Dep. & Amort. | $2,053 | -$2,787 | $1,983 | $1,973 |
| Deferred Tax | -$5,974 | -$7,972 | -$7,797 | -$1,914 |
| Stock-Based Comp. | $2,112 | $2,106 | $2,971 | $0 |
| Change in WC | -$8,126 | $15,322 | -$1,914 | $718 |
| Other Non-Cash | $895 | $5,286 | $1,104 | $2,318 |
| Operating Cash Flow | -$31,626 | -$15,252 | -$33,147 | -$1,817 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$161 | -$299 | -$436 | -$214 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$14,047 | -$52,971 | -$43,329 | -$92,404 |
| Inv. Sales/Matur. | $35,570 | $38,000 | $87,667 | $96,611 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $21,362 | -$15,270 | $43,902 | $3,993 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$517 | -$425 | -$409 | -$155 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$915 | $0 |
| Financing Cash Flow | -$517 | -$425 | -$1,324 | -$155 |
| Forex Effect | -$180 | $134 | $49 | -$202 |
| Net Chg. in Cash | -$10,961 | -$30,813 | $9,480 | $1,819 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $81,452 | $112,265 | $102,785 | $100,497 |
| End Cash | $70,491 | $81,452 | $112,265 | $102,316 |
| Free Cash Flow | -$31,787 | -$15,551 | -$33,583 | -$2,031 |